相似文献
1
Familial autoimmune myasthenia gravis with different pathogenetic antibodies.
J Neurol Neurosurg Psychiatry. 1988 Sep;51(9):1228-30. doi: 10.1136/jnnp.51.9.1228.
2
Nature and Action of Antibodies in Myasthenia Gravis.
Neurol Clin. 2018 May;36(2):275-291. doi: 10.1016/j.ncl.2018.01.001.
3
Experimental autoimmune myasthenia gravis.
J Neurol Neurosurg Psychiatry. 1980 Jul;43(7):568-76. doi: 10.1136/jnnp.43.7.568.
4
Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.
Brain. 2012 Apr;135(Pt 4):1081-101. doi: 10.1093/brain/aws025. Epub 2012 Mar 6.
5
[Myasthenia gravis induced by autoantibodies against MuSK].
Nihon Rinsho. 2008 Jun;66(6):1149-54.
6
[Clinical features of myasthenia related with autoantibodies to muscle specific tyrosine kinase (MuSK)].
Zh Nevrol Psikhiatr Im S S Korsakova. 2010;110(12):72-6.
7
Myasthenia gravis without acetylcholine-receptor antibody: a distinct disease entity.
Lancet. 1986 Jan 18;1(8473):116-9. doi: 10.1016/s0140-6736(86)92259-2.
8
Genetic and antibody-mediated channelopathies at the neuromuscular junction.
Electroencephalogr Clin Neurophysiol Suppl. 1999;50:250-8.
9
Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
Ann Neurol. 2008 Jun;63(6):782-9. doi: 10.1002/ana.21371.
10
[Pseudo-internuclear ophthalmoplegia in myasthenia gravis].
Oftalmologia. 2011;55(3):70-3.
引用本文的文献
1
Familial myasthenia gravis: characterization of an Israeli cohort and systematic review of the literature.
J Neurol. 2025 Jul 10;272(8):498. doi: 10.1007/s00415-025-13236-4.
2
Whole-exome sequencing reveals a rare interferon gamma receptor 1 mutation associated with myasthenia gravis.
Neurol Sci. 2018 Apr;39(4):717-724. doi: 10.1007/s10072-018-3275-8. Epub 2018 Feb 13.
3
The HLA-B*4601-DRB1*0901 haplotype is positively correlated with juvenile ocular myasthenia gravis in a southern Chinese Han population.
Neurol Sci. 2015 Jul;36(7):1135-40. doi: 10.1007/s10072-015-2235-9. Epub 2015 May 8.
4
A retrospective review of 15 patients with familial myasthenia gravis over a period of 25 years.
Neurol Sci. 2012 Aug;33(4):771-7. doi: 10.1007/s10072-011-0818-7. Epub 2011 Nov 5.
5
Familial autoimmune myasthenia gravis: report of four families.
J Neurol Neurosurg Psychiatry. 1995 Jun;58(6):729-31. doi: 10.1136/jnnp.58.6.729.
本文引用的文献
1
Anti-acetylcholine receptor antibodies.
J Neurol Neurosurg Psychiatry. 1980 Jul;43(7):590-600. doi: 10.1136/jnnp.43.7.590.
2
Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis.
Brain. 1980 Sep;103(3):579-601. doi: 10.1093/brain/103.3.579.
3
Myasthenia gravis: long-term correlation of binding and bungarotoxin blocking antibodies against acetylcholine receptors with changes in disease severity.
Neurology. 1983 Oct;33(10):1316-21. doi: 10.1212/wnl.33.10.1316.
4
Myasthenia gravis, thymectomy, and antiacetycholine receptor antibody.
J Neurol. 1980;224(1):9-15. doi: 10.1007/BF00313202.
5
Myasthenia gravis and myasthenic syndromes.
Ann Neurol. 1984 Nov;16(5):519-34. doi: 10.1002/ana.410160502.
6
Familial myasthenia gravis. Report of 27 patients in 12 families and review of 164 patients in 73 families.
Arch Neurol. 1971 Jul;25(1):49-60. doi: 10.1001/archneur.1971.00490010059009.
7
Immunological heterogeneity and cellular mechanisms in myasthenia gravis.
Ann N Y Acad Sci. 1987;505:12-26. doi: 10.1111/j.1749-6632.1987.tb51279.x.
8
Myasthenia gravis without acetylcholine-receptor antibody: a distinct disease entity.
Lancet. 1986 Jan 18;1(8473):116-9. doi: 10.1016/s0140-6736(86)92259-2.
9
Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value.
Neurology. 1976 Nov;26(11):1054-9. doi: 10.1212/wnl.26.11.1054.
10
An assay for antibodies to human acetylcholine receptor in serum from patients with myasthenia gravis.
Clin Immunol Immunopathol. 1977 Jan;7(1):36-43. doi: 10.1016/0090-1229(77)90027-7.
Zotero 插件